Xeroderma Pigmentosum-Trichothiodystrophy overlap patient with novel XPD/ERCC2 mutation. 2013

Henrik H Kralund, and Lilian Ousager, and Nicolaas G Jaspers, and Anja Raams, and Erling B Pedersen, and Else Gade, and Anette Bygum
Department of Dermatology and Allergy Centre; Odense University Hospital; Odense, Denmark.

Xeroderma Pigmentosum (XP), Trichothiodystrophy (TTD) and Cockayne Syndrome (CS) are rare, recessive disorders caused by mutational defects in the Nucleotide Excision Repair (NER) pathway and/or disruption of basic cellular DNA transcription. To date, a multitude of mutations in the XPD/ERCC2 gene have been described, many of which give rise to NER- and DNA transcription related diseases, which share certain diagnostic features and few overlap patients have been described. Despite increasing understanding of the roles of XPD/ERCC2 in mammalian cells, there is still weak predictability of somatic outcome from many of these mutations. We demonstrate a patient, believed to represent an overlap between XP and TTD/CS. In addition to other organ dysfunctions, the young man presented with Photosensitivity, Ichthyosis, Brittle hair, Impaired physical and mental development, Decreased fertility and Short stature (PIBIDS) suggestive of TTD, but lacking the almost patognomonic "tiger tail" banding of the hair under polarized light. Additionally, he developed basal cell carcinoma aged 28, as well as adult onset kidney failure, features normally not associated with TTD but rather XP/CS. His freckled appearance also suggested XP, but fibroblast cultures only demonstrated x2 UV-sensitivity with expected NER and TFIIH-activity decrease. Genetic sequencing of the XPD/ERCC2 gene established the patient as heterozygote compound with a novel, N-terminal Y18H mutation and a known C-terminal (TTD) mutation, A725P. The possible interplay between gene products and the patient phenotype is discussed.

UI MeSH Term Description Entries

Related Publications

Henrik H Kralund, and Lilian Ousager, and Nicolaas G Jaspers, and Anja Raams, and Erling B Pedersen, and Else Gade, and Anette Bygum
August 1997, Proceedings of the National Academy of Sciences of the United States of America,
Henrik H Kralund, and Lilian Ousager, and Nicolaas G Jaspers, and Anja Raams, and Erling B Pedersen, and Else Gade, and Anette Bygum
December 1998, Bulletin du cancer,
Henrik H Kralund, and Lilian Ousager, and Nicolaas G Jaspers, and Anja Raams, and Erling B Pedersen, and Else Gade, and Anette Bygum
December 2012, European journal of human genetics : EJHG,
Henrik H Kralund, and Lilian Ousager, and Nicolaas G Jaspers, and Anja Raams, and Erling B Pedersen, and Else Gade, and Anette Bygum
January 2009, Experimental dermatology,
Henrik H Kralund, and Lilian Ousager, and Nicolaas G Jaspers, and Anja Raams, and Erling B Pedersen, and Else Gade, and Anette Bygum
June 2003, Molecular cell,
Henrik H Kralund, and Lilian Ousager, and Nicolaas G Jaspers, and Anja Raams, and Erling B Pedersen, and Else Gade, and Anette Bygum
March 1992, Mutation research,
Henrik H Kralund, and Lilian Ousager, and Nicolaas G Jaspers, and Anja Raams, and Erling B Pedersen, and Else Gade, and Anette Bygum
January 2008, Advances in experimental medicine and biology,
Henrik H Kralund, and Lilian Ousager, and Nicolaas G Jaspers, and Anja Raams, and Erling B Pedersen, and Else Gade, and Anette Bygum
October 2021, Pediatrics,
Henrik H Kralund, and Lilian Ousager, and Nicolaas G Jaspers, and Anja Raams, and Erling B Pedersen, and Else Gade, and Anette Bygum
September 2019, Pediatric dermatology,
Henrik H Kralund, and Lilian Ousager, and Nicolaas G Jaspers, and Anja Raams, and Erling B Pedersen, and Else Gade, and Anette Bygum
October 2008, Human mutation,
Copied contents to your clipboard!